HTGM logo

HTGM EBITDA

Annual EBITDA

-$20.14 M
-$4.80 M-31.32%

December 31, 2022

Summary

Performance

1-Year Change

-31.32%

3-Year Change

-17.93%

5-Year Change

-22.75%

15-Year Change

-22.75%

HTGM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$11.24 M

3-Year Low

-$20.14 M
HTGM annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HTGM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HTGM next annual earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

Annual Revenue

$6.37 M
HTGM annual revenue is $6.37 million

Annual Net Income

-$21.59 M
HTGM annual net profit is -$21.59 million

Annual EBIT

-$20.73 M
HTGM annual earnings before interest & taxes is -$20.73 million

Annual EPS

-$24.28
HTGM annual earnings per share is -$24.28

Quarterly EBITDA

-$4.83 M
-$407.90 K-9.23%

March 31, 2023

Summary

Performance

3-Month Change

-9.23%

1-Year Change

+20.36%

3-Year Change

+1.04%

5-Year Change

+0.27%

HTGM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.31 M

3-Year Low

-$6.06 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

Quarterly Revenue

$1.03 M
HTGM quarterly revenue is $1.03 million

Quarterly Net Income

-$5.05 M
HTGM quarterly net profit is -$5.05 million

Quarterly EBIT

-$4.91 M
HTGM quarterly earnings before interest & taxes is -$4.91 million

Quarterly EPS

-$2.28
HTGM quarterly earnings per share is -$2.28

TTM EBITDA

-$18.91 M
+$1.23 M+6.13%

March 31, 2023

Summary

Performance

3-Month Change

+6.13%

1-Year Change

-11.07%

3-Year Change

-9.91%

5-Year Change

-10.7%

HTGM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.47 M

3-Year Low

-$20.49 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMprofitabilitymetrics:

TTM Revenue

$6.21 M
HTGM TTM revenue is $6.21 million

TTM Net Income

-$20.15 M
HTGM TTM net profit is -$20.15 million

TTM EBIT

-$19.39 M
HTGM TTM earnings before interest & taxes is -$19.39 million

TTM EPS

-$17.80
HTGM TTM earnings per share is -$17.80

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$20.14 M
HTGM annual EBITDA is -$20.14 million

Annual Net Income

-$21.59 M
HTGM annual net profit is -$21.59 million

Annual Interest Expense

$856.70 K
HTGM annual interest expense is $856.70 thousand

Annual Income Tax

$10.80 K
HTGM annual income tax is $10.80 thousand

Annual D&A

$587.10 K
HTGM annual depreciation & amortization is $587.10 thousand

HTGM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.3%+20.4%-11.1%
3 y3 years-17.9%+1.0%-9.9%
5 y5 years-22.8%+0.3%-10.7%

HTGM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+31.3%at low+15.5%+25.6%+23.3%+8.4%
5 y5-year+31.3%at low+123.4%+25.6%+32.4%+8.4%
alltimeall time+79.1%+12.7%+267.8%+29.9%+664.6%+21.5%

HTG Molecular Diagnostics EBITDA History

DateAnnualQuarterlyTTM
Mar 2023
-
-$4.83 M(+9.2%)
-$18.91 M(-6.1%)
Dec 2022
-$20.14 M(+31.3%)
-$4.42 M(+5.7%)
-$20.14 M(-1.7%)
Sep 2022
-
-$4.18 M(-23.7%)
-$20.49 M(+0.7%)
Jun 2022
-
-$5.48 M(-9.7%)
-$20.34 M(+19.5%)
Mar 2022
-
-$6.06 M(+27.1%)
-$17.02 M(+11.0%)
Dec 2021
-$15.34 M(-17.0%)
-$4.77 M(+18.4%)
-$15.34 M(+7.4%)
Sep 2021
-
-$4.03 M(+86.4%)
-$14.27 M(-5.1%)
Jun 2021
-
-$2.16 M(-50.6%)
-$15.04 M(-16.4%)
Mar 2021
-
-$4.38 M(+18.1%)
-$17.98 M(-2.7%)
Dec 2020
-$18.48 M(+8.2%)
-$3.71 M(-22.7%)
-$18.48 M(-0.5%)
Sep 2020
-
-$4.80 M(-6.0%)
-$18.59 M(+3.4%)
Jun 2020
-
-$5.10 M(+4.6%)
-$17.97 M(+4.5%)
Mar 2020
-
-$4.88 M(+28.1%)
-$17.20 M(+0.7%)
Dec 2019
-$17.08 M(+21.3%)
-$3.81 M(-9.0%)
-$17.08 M(+15.4%)
Sep 2019
-
-$4.18 M(-3.4%)
-$14.80 M(-0.5%)
Jun 2019
-
-$4.33 M(-8.9%)
-$14.88 M(+6.3%)
Mar 2019
-
-$4.75 M(+209.9%)
-$13.99 M(-0.6%)
Dec 2018
-$14.08 M
-$1.53 M(-64.0%)
-$14.08 M(+1.6%)
Sep 2018
-
-$4.26 M(+23.7%)
-$13.86 M(-3.6%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$3.44 M(-28.9%)
-$14.37 M(-10.9%)
Mar 2018
-
-$4.84 M(+268.8%)
-$16.13 M(-1.7%)
Dec 2017
-$16.41 M(-27.7%)
-$1.31 M(-72.5%)
-$16.41 M(-17.7%)
Sep 2017
-
-$4.77 M(-8.2%)
-$19.93 M(-4.2%)
Jun 2017
-
-$5.20 M(+1.5%)
-$20.80 M(-3.4%)
Mar 2017
-
-$5.12 M(+5.9%)
-$21.54 M(-5.1%)
Dec 2016
-$22.69 M(+19.4%)
-$4.83 M(-14.3%)
-$22.69 M(-1.2%)
Sep 2016
-
-$5.64 M(-5.1%)
-$22.97 M(+4.7%)
Jun 2016
-
-$5.94 M(-5.3%)
-$21.93 M(+0.5%)
Mar 2016
-
-$6.27 M(+22.6%)
-$21.82 M(+14.8%)
Dec 2015
-$19.01 M(+49.0%)
-$5.12 M(+11.1%)
-$19.01 M(+8.7%)
Sep 2015
-
-$4.60 M(-21.0%)
-$17.48 M(+10.0%)
Jun 2015
-
-$5.83 M(+68.6%)
-$15.90 M(+17.1%)
Mar 2015
-
-$3.46 M(-3.8%)
-$13.58 M(+6.5%)
Dec 2014
-$12.75 M(+13.5%)
-$3.59 M(+18.9%)
-$12.76 M(+9.6%)
Sep 2014
-
-$3.02 M(-13.8%)
-$11.64 M(+35.1%)
Jun 2014
-
-$3.51 M(+33.2%)
-$8.61 M(+68.7%)
Mar 2014
-
-$2.63 M(+6.5%)
-$5.11 M(+106.5%)
Dec 2013
-$11.24 M(-8.6%)
-$2.47 M
-$2.47 M
Dec 2012
-$12.30 M
-
-

FAQ

  • What is HTG Molecular Diagnostics annual EBITDA?
  • What is the all time high annual EBITDA for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics annual EBITDA year-on-year change?
  • What is HTG Molecular Diagnostics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics quarterly EBITDA year-on-year change?
  • What is HTG Molecular Diagnostics TTM EBITDA?
  • What is the all time high TTM EBITDA for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics TTM EBITDA year-on-year change?

What is HTG Molecular Diagnostics annual EBITDA?

The current annual EBITDA of HTGM is -$20.14 M

What is the all time high annual EBITDA for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high annual EBITDA is -$11.24 M

What is HTG Molecular Diagnostics annual EBITDA year-on-year change?

Over the past year, HTGM annual EBITDA has changed by -$4.80 M (-31.32%)

What is HTG Molecular Diagnostics quarterly EBITDA?

The current quarterly EBITDA of HTGM is -$4.83 M

What is the all time high quarterly EBITDA for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high quarterly EBITDA is -$1.31 M

What is HTG Molecular Diagnostics quarterly EBITDA year-on-year change?

Over the past year, HTGM quarterly EBITDA has changed by +$1.23 M (+20.36%)

What is HTG Molecular Diagnostics TTM EBITDA?

The current TTM EBITDA of HTGM is -$18.91 M

What is the all time high TTM EBITDA for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high TTM EBITDA is -$2.47 M

What is HTG Molecular Diagnostics TTM EBITDA year-on-year change?

Over the past year, HTGM TTM EBITDA has changed by -$1.88 M (-11.07%)